Catalysts

Figures converted from GBP at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Catalysts — What Can Move the Stock

The next six months hinge on a single hard-dated event: Wise begins trading on Nasdaq on Monday 11 May 2026, ten days from today, with the LSE moving to a secondary listing and the FY26 results landing in USD under US GAAP in early June. Everything else — the $46m of one-off costs landing in the FY26 print, the OCC trust-bank decision, the multi-state AML monitor reports, the $33m share-repurchase programme that is roughly half complete — sits behind that single ten-day window. The calendar after the listing is busy but lower-impact until November's H1 FY27 print is the first clean test of whether the deliberate margin compression actually produces the volume response management has promised.

Hard-dated catalysts (next 6m)

4

High-impact catalysts

3

Days to next hard date

10

Signal quality (1-5)

4.0

1. Ranked Catalyst Timeline

No Results

The ranking puts the Nasdaq debut, the June FY26 print, and the AML monitor first because they share the same underlying dynamic — they each test whether the FY24-FY25 reported margin level is the new baseline or a rate-cycle peak. The OCC charter is the only purely-future-positive catalyst on the page; everything else is a beat-or-miss against expectations the company has already set.

2. Impact Matrix

No Results

Three of these six items resolve the central debate identified in the bull/bear work: whether the FY24-25 margin step-change was rate-cycle pull-forward (bear) or a structural re-rating to deposit-franchise economics (bull). The Nasdaq listing is multiple-driven; the FY26 print and the H1 FY27 print are earnings-driven; the OCC charter is structural; the monitor and Platform inflection are tail risks/optionality.

3. Next 90 Days

The 90-day window is unusually concentrated for this name — three of the four highest-ranked catalysts cluster between 8 May and early June.

No Results

The 90-day window is unusually rich for an LSE-primary fintech: the listing, the first US-GAAP earnings, an index review, an AGM and a quarterly trading update all land within ten weeks. The order of release matters — if the listing flow is weak, the FY26 print has to do all the work to defend the multiple, and a missed UPBT band would compound rather than offset.

4. What Would Change the View

Three observable signals over the next six months would force the bull-versus-bear debate to resolve. First, whether Nasdaq ADV materially widens above the $21m LSE baseline within 30 sessions — this is the cleanest empirical test of the listing-rerating thesis, and a failure here removes the largest single bull catalyst of the year. Second, the FY26 UPBT margin print stripped of the $46m one-off costs: if the underlying margin lands inside 13-16% it ratifies the management framework and supports the variant thesis that the rate-cycle reversal is already priced; if it slips below the floor the bear's "rate windfall mispricing" thesis becomes the consensus read. Third, whether the Q1 FY27 take rate stabilises in the 50-52bps band rather than continuing to compress: a flat take rate with volume above 20% would confirm the scale-economies-shared flywheel; continued compression with volume below 20% would prove what management is calling Mission Zero is in fact pricing-pressure-as-a-feature. Together these three signals — listing flow, underlying margin under the new regime, and take-rate stabilisation — are the event path that would force a portfolio manager to update.